 |
PDBsum entry 2q7z
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
2q7z
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
375:102-118
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
|
|
P.B.Furtado,
C.Y.Huang,
D.Ihyembe,
R.A.Hammond,
H.C.Marsh,
S.J.Perkins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human complement receptor type 1 (CR1, CD35) is a type I membrane-bound
glycoprotein that belongs to the regulators of complement activity (RCA) family.
The extra-cellular component of CR1 is comprised of 30 short complement
regulator (SCR) domains, whereas complement receptor type 2 (CR2) has 15 SCR
domains and factor H (FH) has 20 SCR domains. The domain arrangement of a
soluble form of CR1 (sCR1) was studied by X-ray scattering and analytical
ultracentrifugation. The radius of gyration R(G) of sCR1 of 13.4(+/-1.1) nm is
not much greater than those for CR2 and FH, and its R(G)/R(0) anisotropy ratio
is 3.76, compared to ratios of 3.67 for FH and 4.1 for CR2. Unlike CR2, but
similar to FH, two cross-sectional R(G) ranges were identified that gave R(XS)
values of 4.7(+/-0.2) nm and 1.2(+/-0.7) nm, respectively, showing that the SCR
domains adopt a range of conformations including folded-back ones. The distance
distribution function P(r) showed that the most commonly occurring distance in
sCR1 is at 11.5 nm. Its maximum length of 55 nm is less than double those for
CR2 or FH, even though sCR1 has twice the number of SCR domains compared to CR2
Sedimentation equilibrium experiments gave a mean molecular weight of 235 kDa
for sCR1. This is consistent with the value of 245 kDa calculated from its
composition including 14 N-linked oligosaccharide sites, and confirmed that sCR1
is a monomer in solution. Sedimentation velocity experiments gave a
sedimentation coefficient of 5.8 S. From this, the frictional ratio (f/f(0)) of
sCR1 was calculated to be 2.29, which is greater than those of 1.96 for CR2 and
1.77 for FH. The constrained scattering modelling of the sCR1 solution structure
starting from homologous SCR domain structures generated 5000 trial
conformationally randomised models, 43 of which gave good scattering fits to
show that sCR1 has a partly folded-back structure. We conclude that the
inter-SCR linkers show structural features in common with those in FH, but
differ from those in CR2, and the SCR arrangement in CR1 will permit C3b or C4b
to access all three ligand sites.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Organisation of the 30 SCR domains in sCR1. (a)
Schematic diagram showing the main features in the 30 SCR
domains. The long homologous repeats LHR-A to LHR-D are
indicated in bracketed ranges. sCR1 contains 25 putative
N-linked oligosaccharide sites (• and ○), of which the 14
sites used for the modelling of sCR1 are shown by ○. The six
sites underneath the cartoon schematically correspond to those
adjacent to β-strand β7. The three binding sites for C3b and
C4b at the start of LHR-A, LHR-B and LHR-C are also indicated.
(b) Sequence alignment of the 30 SCR domains in sCR1. Dashes are
used to preserve the alignment. The SCR sequence numbering of
the mature polypeptide (in brackets) is from residue 1 at the
start of the signal peptide (not shown). The four conserved Cys
residues (denoted C1–C4) and the conserved Trp residue are
highlighted in red. The inter-SCR linker sequences start after
the last Cys residue (C4) and end at the first Cys residue (C1)
in each SCR and are shown in green. The Thr1876Ile substitution
in SCR-29 is shown in blue (Materials and Methods). The six most
frequently conserved β-strands observed in the SCR models are
represented by grey shaded residues in the alignment according
to the DSSP analyses, and are labelled β2 and β4 to β8 to
follow previous conventions (see the text). The locations of the
25 putative N-linked oligosaccharide sites are shown in green
and yellow when these were used in the sCR1 models, and in red
and yellow when these were not used.
|
 |
Figure 6.
Figure 6. Sedimentation velocity analyses of sCR1 using the
SEDFIT c(s) method. Boundary fits of the sedimentation scans are
shown for (a) interference and (b) absorbance data at 0.21 mg/ml
at a rotor speed of 25,000 r.p.m. Only every fifth scan of the
200 interference and absorbance scans are shown for clarity. The
position of the major sedimentation species in the c(s)
distribution plots for (c) interference and (d) for absorbance
data is arrowed.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2008,
375,
102-118)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Li,
J.Gor,
and
S.J.Perkins
(2010).
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
|
| |
Biochem J,
431,
63-72.
|
 |
|
|
|
|
 |
A.Yamaguchi,
H.Takagawa,
H.Iwakaji,
S.Miyagawa,
P.C.Wang,
and
N.Ishii
(2009).
Construction of the plasmid, expression by Chinese hamster ovary cell, purification and characterization of the first three short consensus repeat modules of human complement receptor type 1.
|
| |
J Biochem,
145,
533-542.
|
 |
|
|
|
|
 |
D.Liu,
and
Z.X.Niu
(2009).
The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35).
|
| |
Immunopharmacol Immunotoxicol,
31,
524-535.
|
 |
|
|
|
|
 |
S.J.Perkins,
A.I.Okemefuna,
R.Nan,
K.Li,
and
A.Bonner
(2009).
Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights.
|
| |
J R Soc Interface,
6,
S679-S696.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |